US pharma regulator cuts drug filing fee by 8%

The US drug regulator, Food and Drug Administrator (FDA), has lowered the fee charged for generic drug applications by 8 per cent. This will apply on filings made after October this...... Published By: BusinessLine - Economy - 2 days ago
Share |